Torrent Buy Of Elder Pharma Formulations Business Clears India's CCI
This article was originally published in PharmAsia News
Executive Summary
Torrent Pharma's $333.5 million purchase of the formulations business of Elder Pharma has received the approval of the Competition Commission of India, which considers antitrust issues.